Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen Inc. | -0.03% | 358.42 | 1.2% | $822.65m | |
| AMGN | Amgen Inc. | -0.43% | 191.97 | 1.2% | $549.69m | |
| CELG | Celgene Corporation | -0.13% | 85.67 | 1.2% | $541.62m | |
| GILD | Gilead Sciences, Inc. | 0.68% | 77.65 | 0.9% | $486.04m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.62% | 134.51 | 16.6% | $345.10m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.23% | 180.72 | 1.9% | $321.35m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.12% | 366.42 | 2.6% | $293.85m | |
| ILMN | Illumina, Inc. | 0.82% | 309.80 | 3.5% | $269.42m | |
| BLUE | Bluebird Bio, Inc. | 0.06% | 179.65 | 15.7% | $208.27m | |
| NKTR | Nektar Therapeutics | 1.82% | 48.75 | 5.6% | $178.62m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.37% | 135.15 | 2.0% | $175.76m | |
| FMI | Foundation Medicine, Inc. | 0.09% | 136.93 | 8.8% | $160.93m | |
| EXAS | Exact Sciences Corporation | 0.81% | 67.28 | 25.4% | $160.59m | |
| EXEL | Exelixis, Inc. | 0.05% | 21.34 | 6.4% | $135.83m | |
| A | Agilent Technologies, Inc. | 2.03% | 64.27 | 1.5% | $132.91m |
Company Profile
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs targets the development of carbohdrate molecules which offers offer alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.